Louise Rodino-klapac - Net Worth and Insider Trading
Louise Rodino-klapac Net Worth
The estimated net worth of Louise Rodino-klapac is at least $8 Million dollars as of 2024-11-10. Louise Rodino-klapac is the Head of R&D, CSO of Sarepta Therapeutics Inc and owns about 65,678 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $8 Million. Details can be seen in Louise Rodino-klapac's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louise Rodino-klapac has not made any transactions after 2021-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Louise Rodino-klapac
Louise Rodino-klapac Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louise Rodino-klapac owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Louise Rodino-klapac’s form 4 insider trades.
Insider Ownership Summary of Louise Rodino-klapac
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2021-11-24 | Chief Scientific Officer |
Louise Rodino-klapac Latest Holdings Summary
Louise Rodino-klapac currently owns a total of 1 stock. Louise Rodino-klapac owns 65,678 shares of Sarepta Therapeutics Inc (SRPT) as of November 24, 2021, with a value of $8 Million.
Latest Holdings of Louise Rodino-klapac
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2021-11-24 | 65,678 | 121.61 | 7,987,102 |
Holding Weightings of Louise Rodino-klapac
Louise Rodino-klapac Form 4 Trading Tracker
According to the SEC Form 4 filings, Louise Rodino-klapac has made a total of 1 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 3,780 shares on November 24, 2021, which cost Louise Rodino-klapac around $299,867.
Insider Trading History of Louise Rodino-klapac
- 1
Louise Rodino-klapac Trading Performance
GuruFocus tracks the stock performance after each of Louise Rodino-klapac's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louise Rodino-klapac is -6.37%. GuruFocus also compares Louise Rodino-klapac's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louise Rodino-klapac within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louise Rodino-klapac's insider trading performs compared to the benchmark.
Performance of Louise Rodino-klapac
Louise Rodino-klapac Ownership Network
Ownership Network List of Louise Rodino-klapac
Ownership Network Relation of Louise Rodino-klapac
Louise Rodino-klapac Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Louise Rodino-klapac is the Chief Scientific Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Louise Rodino-klapac made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .
In summary, during the past 3 months, insiders sold 5,985 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net purchase of 31,053 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Louise Rodino-klapac Mailing Address
Above is the net worth, insider trading, and ownership report for Louise Rodino-klapac. You might contact Louise Rodino-klapac via mailing address: 215 First Street, Ste 415, Cambridge Ma 02142.